Introduction
============

Cystic echinococcosis (CE), is an important zoonotic parasitic disease with global distribution including Iran ([@B1], [@B2]). The infection is particularly important in terms of economic, medical and veterinary aspects in endemic areas ([@B3]). Human is usually infected following ingestion of parasite eggs via contaminated foods. The eggs develop to cysts in any organ especially in the liver and lungs ([@B4]). Diagnosis of hydatid disease is initially based on clinical signs followed by the imaging of suspected organs combined with serological tests ([@B5]--[@B7]). New techniques such as proteomics are also used ([@B8]). Diagnosis of the disease in human is difficult due to the absence of specific clinical signs; hence imaging methods may not be able to differentiate between hydatid cysts, tumors, and other lesions ([@B9]). Medical and surgical treatments are undertaken for the disease but surgery has been the most important and effective method for treating hydatid disease. However, the rupture of the cyst during surgery has been one of the major problems leading to the formation of secondary hydatid cysts in the abdominal cavity. Therefore, surgeons usually utilize several synthetic or natural protoscolicidal agents in treatment attempts to prevent this important complication ([@B10]--[@B13]).

Iran is an important region in the Middle East where various species of animals become infected by *E. granulosus* ([@B2]). Moreover, human CE is also documented in many studies in different parts of Iran ([@B2], [@B6], [@B14], [@B15]).

During recent years, the molecular characterization of several organisms such as different parasites has been developed in many areas. In this context, genotype characterization of *E. granulosus* could help different aspects of the echinococcosis including epidemiology, diagnosis, treatments and control strategies of this important disease ([@B4], [@B15]).

Five genotypes of *E. granulosus* including *E. granulosus* sensu stricto (G1--G3 complex), *E. ortleppi* (G5), and *E. canadensis* (G6) have been reported from animal and/or human in Iran ([@B4], [@B15]--[@B21]).

Considering the possibility of organ-tropism in *E. granulosus* strains, the present study was aimed to identify the genotypes of *E. granulosus* in different organs of patients' undergone surgery in Baqiyatallah Hospital, Tehran, Iran.

Materials and Methods
=====================

Overall, 29 out of 104 formalin-fixed paraffin-embedded tissues (FFPT) including liver (N: 14) lungs (N: 6) abdomen (N: 2), pancreas (N: 2) and each from spleen, gallbladder and muscles (N: 1) and also unknown organ (N: 2) from patients (19 males and 10 females) with histologically confirmed CE obtained from Baqiyatallah Hospital, Tehran, Iran from 2005--2015.

After xylene de-paraffinization and methanol rehydration (100%, 90%, 80%, 70 % and 60%) of the tissue sections from all samples, DNA was extracted using Tissue DNA Extraction Micro Kit (Favorgen, Taiwan) according to the manufacturer's instructions. The quality of DNA was checked by NanoDrop (Biotek, USA, version: Epoch 2) and DNA was subsequently used as a template for polymerase chain reaction (PCR) using amplification of a partial mitochondrial DNA fragment of cox1. JB3 (TTTTTTGGGCATCCTGAGGTTTAT) and JB4.5 (TAAAGAAAGAACATAATGAAAATG) sequences were utilized as forward and reverse primers respectively ([@B22]). PCR was carried out in the final volume of 50 μL, including 4 μL (50--100 ng) of genomic DNA, 2 μL (25 p. mol) of each primers and 25μL of master mix including Taq DNA polymerase, Mgcl2, dNTP, PCR buffer and loading dye (Cinaclon, Iran) and 17 μL of DDW under the following conditions: 5 min at 94 °C as an initial denaturation step, followed by 35 cycles of 30 sec at 94 °C, 45 sec at 50 °C, 35 sec at 72 °C and a final extension step of 10 min at 72 °C. Negative (no added DNA) and positive controls were included in each PCR cycle. The amplification products were analyzed by electrophoresis in ethidium bromide-stained 1% agarose gel prepared in TAE buffered medium (65 mM Tris-HCl, 22.5 mM boric acid, 1.25 mM EDTA, pH 8.3) and subsequently visualized using an UV trans-illuminator (UVitec, Cambridge, UK).

A panel of 29 PCR amplicons for the cox1gene was purified using FavorPrep ^TM^ GEL/PCR Purification Kit (Favorgen, Taiwan) and subjected to sequencing in two directions, using the same PCR primer set (First BASE Laboratories Sdn Bhd-604944X, Malaysia).

The sequences of the cox1 gene were deposited in the GenBank database. Blast software was applied in order to preliminary identification and comparison of our sequences with other deposited ones in GenBank (<http://www.ncbi.nlm.nih.gov>). A Phylogenetic tree was drawn using our sequences and a few cases obtained from GenBank ([Table 1](#T1){ref-type="table"}). Alignment was carried out using ClustalW and the aligned sequences manually refined in BioEdit software (ver. 5.0.6) ([@B23]); maximum likelihood (ML) was inferred by MEGA 5 software for phylogenetic tree construction ([@B24]).

###### 

The genotype of *Echinococcus granulosus* isolates identified by partial mitochondrial cox1 sequence in Baqiyatallah hospital (Tehran, Iran) and relevant information pertaining to the origins of sequences used for subsequent phylogenetic analyses ([Fig. 2](#F2){ref-type="fig"})

  ***Code (No)***   ***Identification number of isolates***   ***Geographic origin Country (City or County)***   ***Organ localization***   ***Accession Number***                     ***Strain (Genotype***   ***References***
  ----------------- ----------------------------------------- -------------------------------------------------- -------------------------- ------------------------------------------ ------------------------ ------------------
  1                 6451                                      Iran (Tehran)                                      Liver                      MH244469                                   G1                       Present study
  2                 13910                                     Iran (Melard)                                      Unknown                    MH244470                                   G1                       Present study
  3                 14207                                     Iran (Tehran)                                      Liver                      MH244471                                   G1                       Present study
  4                 3455                                      Iraq (not reported)                                Liver                      MH244472                                   G1                       Present study
  5                 4119                                      Iran (Rasht)                                       Lung                       MH244473                                   G1                       Present study
  6                 6493                                      Iran (Kermanshah)                                  Lung                       MH244474                                   G1                       Present study
  7                 3865                                      Iran (Karaj)                                       Lung                       MH244475                                   G1                       Present study
  8                 1611                                      Iran (not reported)                                Pancreas                   MH244476                                   G1                       Present study
  9                 2875                                      Iran (not reported)                                Pancreas                   MH244477                                   G1                       Present study
  10                510                                       Iran (not reported)                                Abdomen                    MH244478                                   G1                       Present study
  11                5262                                      Iran (not reported)                                Unknown                    MH244479                                   G1                       Present study
  12                560                                       Iran (not reported)                                Muscle                     MH244480                                   G1                       Present study
  13                360                                       Iran (Golestan-Bandar-e-Gaz)                       Liver                      MH244481                                   G1                       Present study
  14                644                                       Iran (Khomein)                                     Lung                       MH244482                                   G1                       Present study
  15                7840                                      Iran (Pakdasht)                                    Liver                      MH244483                                   G1                       Present study
  16                6355                                      Iran (Tehran)                                      Abdomen                    MH244484                                   G1                       Present study
  17                2703                                      Iran (Baghmalek)                                   Liver                      MH244485                                   G1                       Present study
  18                603                                       Iran (Tehran)                                      Gallbladder                MH244486                                   G1                       Present study
  19                1583                                      Iran (Tehran)                                      Spleen                     MH244487                                   G1                       Present study
  20                KU37                                      Iraq (Kurdistan)                                   Not reported               MF004309[\*](#TFN1){ref-type="table-fn"}   G1                       \(34\)
  21                EG44                                      Peru                                               Not reported               AB688621[\*](#TFN1){ref-type="table-fn"}   G1                       \(10\)
  22                Not reported                              Australia (Tasmania)                               Not reported               M84662[\*](#TFN1){ref-type="table-fn"}     G2                       \(22\)
  23                Not reported                              India                                              Not reported               M84663[\*](#TFN1){ref-type="table-fn"}     G3                       \(22\)
  24                KH10                                      Iran (Birjand)                                     Liver                      KP751430[\*](#TFN1){ref-type="table-fn"}   G6                       \(21\)
  25                (Out group)                               China: Inner Mongolia                              Not reported               AB461420[\*](#TFN1){ref-type="table-fn"}   *E.m*                    \(35\)

GenBank samples for comparison

Approval of the study protocol was received from the Ethical Committee of Baqiyatallah University of Medical Sciences.

Results
=======

Twenty-nine fragments of human CE isolates with around 450 bp long were successfully amplified within cox1 gene ([Fig. 1](#F1){ref-type="fig"}).

![Gel electrophoresis of cox1--PCR products. Lanes 1--4: *E. granulosus* isolates; Lane N: negative control; Lane P: positive control; Lane M, 100 bp DNA ladder](IJPA-15-130-g001){#F1}

Liver and lungs were the most organs involved with 14 (48.27%) and 6 (20.68%) cases respectively. Other organs have been shown to be 9(31.04%) including two in abdomen (6.9%), two in pancreas (6.9%), one (3.45%) in gallbladder, one (3.45%) in muscle and one(3.45%) in heart. Furthermore, the organ of the two (6.9%) isolates have not been reported.

Nineteen out of 29 isolates including liver (N: 6) lungs (N: 4) abdomen (N: 2), pancreas (N: 2) and each of spleen, gallbladder and muscles (N: 1), and unknown organ (N: 2) obtained from paraffin embedded blocks of human CE resulted reasonable sequences in both directions. All 19 isolates regardless of their organs involved were recognized as *E. granulosus* sensu stricto (G1) ([Table 1](#T1){ref-type="table"}). The sequence alignments of the isolates displayed two profiles. Sequence profiles were deposited in GenBank with accession numbers MH244469--87. A consensus tree was made and the polymorphism points were shown ([Fig. 2](#F2){ref-type="fig"}).

![Genetic relationships of nineteen *Echinococcus granulosus* isolates from the Baqiyatallah hospital and selected GenBank sequence samples based on phylogenetic analysis of partial cox1 sequence data ([Table 1](#T1){ref-type="table"}). AB461420: *E. multilocularis* isolate from GenBank as the out-group](IJPA-15-130-g002){#F2}

Discussion
==========

Despite many efforts in control and prevention of CE, the disease is one of the most important zoonotic tissue helminthic infections in the world especially in Mediterranean regions ([@B25]).

Different aspects of the disease including the molecular perspective of human and animal CE is useful for control programs. Recently many researchers have utilized molecular tools to access the information about parasite genotypic diversity ([@B16]--[@B21], [@B26]). Several genes including both coding and non-coding regions have used for intra-species differentiation; however, mitochondrial markers such as cox1 have shown great power in genetic discrimination ([@B25]--[@B28]).

The G6 genotype, which has already been reported as a main causative agent of brain CE in Iran ([@B16]--[@B17]); is widespread in Birjand, Eastern Iran ([@B21]).

Application of formalin-fixed, paraffin-embedded tissue samples have been used for discrimination of genotypes in different localities to show the geographical distribution of the genotypes ([@B29]).

In this context, in the present study 29 human CE samples obtained from various organs were successfully amplified within cox1 gene of which only 19 isolates including liver (31.58%) lungs (21.05%) abdomen (10.52%), pancreas (10.52%) and each of spleen, gallbladder and muscle (5.27%) plus unknown organ (10.52%) were shown an acceptable bidirectional sequences. All isolates regardless of the organ involved were recognized as *E. granulosus* senso strcto (G1) which supports previous reports as G1 as the more prevalent strain in Iran ([@B15], [@B18]--[@B19], [@B29],[@B30]).

A study on formalin-fixed, paraffin-embedded tissue samples from Alborz, Tehran, and Kerman provinces on 125 samples reported 56%, 40%, 3.2% and 0.8% of isolates as G1, G6, G3, and G2 genotypes, respectively. Despite the high number of samples, there is no report of the organ involved in that investigation ([@B29]).

A study on 334 liver and lungs CE, originated from sheep, cattle, goats and human by sequencing of ITS1 genes in Khuzestan province showed only G1 strain in all tested samples ([@B30]). However, another study on human brain CE showed them as G6 while other samples from the human liver were reported as G1 strain which showed organ tropism in *E. granulosus* ([@B16]).

Molecular study on 30 samples from hospitalized patients in Isfahan showed them as G1 which is similar to our results ([@B31]). A study on the paraffin embedded of CE in Mazandaran Province showed the human isolates as *E. granulosus* sensu stricto ([@B32]).

Overall, 47 human CE from two hospitals in Tehran were amplified based on cox1 and nad1 genes. Sixteen (53.3%), 13 (43.3%), and 1 (3.3%) samples were related to three organs including lung, liver and spleen, respectively. Twenty-six and 3 of the 29 isolates were related to G1, and G3 strains, respectively. Only one G6 isolate was obtained from the lungs ([@B33]).

The lack of diversity in the isolates of our study could be because G1 is a common strain worldwide consequently, Iran and the number of samples although from different geographical origin (Tehran, Golestan, Kermanshah, Central provinces and even Iraq) is parallel to the most prevalent strain in those areas.

Conclusion
==========

Genetic diversity of hepatic and non-hepatic cystic echinococcosis in Baqiyatallah Hospital, Tehran, during ten years showed that *E. granulosus* sensu stricto is predominant. This means that more attention should be directed to the diagnosis and treatment protocols to this important genotype in this geographic region.
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